Radiotherapy and Oncology

Papers
(The H4-Index of Radiotherapy and Oncology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group183
Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance181
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial129
A physicochemical model of reaction kinetics supports peroxyl radical recombination as the main determinant of the FLASH effect116
Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review110
What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans110
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma105
A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy94
Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma92
Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies91
The tubarial salivary glands: A potential new organ at risk for radiotherapy79
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)79
In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH75
Mechanisms of radiation-induced endothelium damage: Emerging models and technologies74
A deep learning approach to generate synthetic CT in low field MR-guided adaptive radiotherapy for abdominal and pelvic cases69
Deep learning-based synthetic CT generation for paediatric brain MR-only photon and proton radiotherapy69
Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience68
Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment68
May oxygen depletion explain the FLASH effect? A chemical track structure analysis67
Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results67
A systematic review on the usage of averaged LET in radiation biology for particle therapy64
ADC measurements on the Unity MR-linac – A recommendation on behalf of the Elekta Unity MR-linac consortium63
Clinical evaluation of atlas- and deep learning-based automatic segmentation of multiple organs and clinical target volumes for breast cancer63
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes62
Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy62
First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardia62
Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction60
Development and validation of a deep learning algorithm for auto-delineation of clinical target volume and organs at risk in cervical cancer radiotherapy57
IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer56
Deep learning-based auto-segmentation of organs at risk in high-dose rate brachytherapy of cervical cancer55
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma55
Improvement of prediction and classification performance for gamma passing rate by using plan complexity and dosiomics features55
Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey53
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials53
First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays52
ESTRO ACROP guideline for target volume delineation of skull base tumors52
Dose prediction with deep learning for prostate cancer radiation therapy: Model adaptation to different treatment planning practices51
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial50
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma49
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review49
Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977–200548
Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?47
FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model46
Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits46
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus44
0.03330397605896